Understanding how genomic information is translated into gene regulation has been the subject of intense scien tific investigation over the past several decades. Until recently, most studies focused on detailed characteriza tion of a particular gene or gene family. These studies resulted in the development of general principles of gene regulation, but genomescale studies are now prompting reexamination of some of these principles.
The established view of transcriptional regulation is that cisregulatory elements, such as promoters and enhancers, and proteins that bind to these elements con trol different levels of transcription of different genes 1, 2 . Promoters are composed of common sequence elements, such as a TATA box and an initiator sequence, and binding sites for other transcription factors, which work together to recruit the general transcriptional machinery to the transcriptional start site (TSS). Enhancers also contain binding sites for transcription factors but are located some distance from the site of transcription initiation. Transcriptional activity that results from general factors binding to the core promoter is usually low, but it can be increased by the binding of sitespecific factors to proximal promoter regions, which can help to recruit or stabilize the interaction of the general factors at the core promoter. Promoter activity can be further stimulated by the binding of factors to distal enhancer regions and the subsequent recruitment of a histonemodifying enzyme that creates a more favourable chromatin environment for transcription or of a kinase that induces a bound i nitiation complex to begin elongation (FIG. 1) . Transcription can also be modulated by repressive factors that bind to repressing sequences and/or silencers far from the TSS, which can interfere with activator binding (and thus pre vent recruitment of the general transcriptional machinery) or recruit histonemodifying complexes that create repressive chromatin structures.
Recent genomescale studies have enabled more precise definition of thousands of promoters for known genes and have identified many previously unrecognized transcription units, which has revealed that some pre vious assumptions about transcriptional regulation are not correct. For example, based on the detailed char acterization of a small subset of promoters, a typical RNA polymerase II (RNAPII) promoter was thought to contain a TATA box located 30 bp upstream of the TSS. However, we now know that TATAdriven promoters are the exception and not the rule 3, 4 . Other recent genomic studies suggest that ~50% of human genes have alterna tive promoters 5 , indicating that regulatory sequences for a particular gene can be spread over a considerable distance. Clearly, access to large data sets documenting RNA expression and transcription factor binding on a genomewide scale now provides an exciting opportunity for investigators to reevaluate previous models of tran scriptional regulation. Of particular interest is the role of sitespecific DNAbinding factors, which is the focus of this Review.
In humans, it has been estimated that there are 200-300 transcription factors that bind to core promoter elements and that can be considered as components of the general transcriptional machinery; such transcrip tion factors include subunits of RNA polymerases and
TATA box
A consensus sequence in promoters that is enriched in thymine and adenine residues and is important for the recruitment of the general transcriptional machinery at some promoters.
of complexes, such as transcription factor II D (TFIID), that are required for transcription of most proteincoding genes. In addition, there are ~1,400 transcription factors that have sequencespecific DNAbinding properties and thus regulate only a subset of genes by binding to site specific cis elements [6] [7] [8] . Interestingly, the sitespecific fac tors tend to be expressed either in all (or most) tissues or in one or two tissues, suggesting either a very broad or very specific function 7 . Alterations in gene expression caused by the inappropriate level, structure or function of a transcriptional regulator have been associated with a diverse set of human diseases, including cancers and developmental disorders 9 ; for example, 164 transcription factors have been shown to be directly responsible for 277 diseases 7 . This is undoubtedly a large underestimation of the importance of transcription factors in human disease, because most human transcription factors are uncharac terized 7 . Owing to the paucity of our knowledge concern ing the function of transcription factors and the likelihood that increased knowledge of transcription factors will lead to increased insight into the causes of human diseases, it is of utmost importance that we expand our under standing of how sitespecific transcription factors con tribute to gene regulation. Crucial questions that need to be addressed are: where do transcription factors bind in the genome, how is specificity of binding achieved, what features of chromatin influence the ability of transcrip tion factors to stably interact with the genome, and how is binding of a transcription factor related to its subsequent function in respect to regulation of a nearby gene?
Fortunately, recent advances in chromatin immuno precipitation followed by microarray (ChIP-chip) or by sequencing (ChIP-seq)
, and similar techniques such as DamID, have allowed investigators to create a global map of specific protein-DNA interactions in a given cell type in a single experiment [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . binding sites identified from these ChIP studies [20] [21] [22] [23] [24] [25] [26] [27] [28] are categorized relative to genomic features such as the nearest gene, the frequency of binding relative to gene structure (for example, binding to a promoter, enhancer, exon or intron) and the type of chromatin domain. The cost of ChIP-seq depends partly on the depth of sequencing, but an estimate is that 10-12 million uniquely mapped reads should be suffi cient for most human transcription factors, and this can be obtained in 1 or 2 lanes of sequencing for a cost of US$1,000-2,000. because multiple DNA microarrays are needed to cover the entire human genome, comprehen sive studies by ChIP-chip are more expensive. However, for certain applications (such as detailed analyses of a pro tein complex binding to a small segment of a genome), a focused ChIP-chip experiment currently remains more costeffective than a genomewide ChIP-seq analysis.
This Review summarizes recent discoveries provided by genomewide profiling of sitespecific transcription factors and how they have led to new insights regarding patterns of transcription factor binding. I also discuss how binding specificity of transcription factors is achieved and what features of chromatin influence the ability of tran scription factors to interact stably with the genome. The focus is on the human genome, although relevant insights from other organisms are also incorporated (in particular when studies using model organisms are more advanced than similar studies of the human genome), as it is likely that the implications of transcription factor recruitment for gene regulation will be similar across all eukaryotes. Importantly, in addition to providing new information, genomewide studies have challenged our understand ing of gene regulation, raising questions such as: why do certain transcription factors bind to so many places in the genome, and why does so much of the regulation seem to be through steps that occur after recruitment Figure 1 | transcriptional regulation by promoters and enhancers. General transcription factors (green ovals) bind to core promoter regions through recognition of common elements such as TATA boxes and initiators (INR). However, these elements on their own provide very low levels of transcriptional activity owing to unstable interactions of the general factors with the promoter region. Promoter activity can be increased (represented by +) by site-specific DNA-binding factors (red trapezoid) interacting with cis elements (dark blue box) in the proximal promoter region and stabilizing the recruitment of the transcriptional machinery through direct interaction of the site-specific factor and the general factors (step 1). Promoter activity can be further stimulated to higher levels by site-specific factors (orange octagon) binding to enhancers (step 2). The enhancer factors can stimulate transcription by (bottom left) recruiting a histone-modifying enzyme (for example, a histone acetyltransferase (HAT)) to create a more favourable chromatin environment for transcription (for example, by histone acetylation (Ac)) or by (bottom right) recruiting a kinase that can phosphorylate (P) the carboxy-terminal domain of RNA polymerase II and stimulate elongation.
Box 1 | Chromatin immunoprecipitation methods
Briefly, chromatin immunoprecipitation (ChIP) (see the figure) involves crosslinking DNA-binding proteins to DNA by treating cells with formaldehyde and preparing chromatin by sonication or enzymatic digestion. An immunoprecipitation of the crosslinked chromatin is performed using an antibody that recognizes a specific transcription factor or histone isoform, which results in the identification of all the binding sites in the genome for the factor of interest. After purification of the precipitated fragments, the sample can be analysed by PCR to study particular genes. However, genome-wide analysis can be performed by microarray (ChIP-chip) or sequencing (ChIP-seq).
For ChIP-chip, the immunoprecipitated sample and input DNA, as a control, are labelled with fluorescent dyes and hybridized to microarrays. Binding sites are identified by the intensity of the signal of the immunoprecipitated sample in relation to the signal of the input DNA sample at each probe on the microarray using various ChIP-chip peak-calling programs 21, 22 . For a single ChIP-chip experiment, most investigators use between 10 6 and 10 7 cells; however, recent methodological improvements using amplification methods have enabled successful ChIP-chip experiments with as few as 10 4 cells 76-79 . For ChIP-seq, the immunoprecipitated sample is used to create a library that is analysed using high-throughput next-generation sequencers. Binding sites are identified using various ChIP-seq peak-calling programs 16, 26, 27, 81, 82 , all of which identify target sites based on the number of sequenced tags from the ChIP library corresponding to each position in the genome. For a ChIP-seq experiment designed to map binding of a site-specific factor, most investigators use 10 7 to 10 8 cells, although 10 4 to 10 5 cells is sufficient for the ChIP-seq analysis of certain histone modifications 82 . It is important to note that because ChIP assays require such large numbers of cells, the observed peaks in either ChIP-chip or ChIP-seq represent an average level of binding of a factor at a particular site in the cell population. Thus, a small peak could represent very strong binding in only a subset of the cells (for example, cells at one stage of the cell cycle) or modest binding in the entire cell population. ChIP-seq experiments, which allow binding to be analysed at all unique overlapping oligomers of a certain length (usually 27-50 nucleotides) in the genome, can provide very high resolution mapping of transcription factor-binding sites. For example, three-quarters of all the ChIP-seq peak positions for the DNA-binding proteins CCCTC-binding factor (CTCF), neuron-restrictive silencer factor (NRSF) and signal transducer and activator of transcription 1 (STAT1) are within 18, 27 and 51 bp, respectively, of the nearest motif for that factor 81 . In general, genome-scale ChIP-chip experiments are less precise in mapping the exact location of a binding site because the oligomers on the array are not overlapping; if overlapping oligomers were used, a prohibitively large number of arrays would be required, so the oligomers are instead spaced approximately 35-100 nucelotides apart. 
CpG island
A sequence of at least 200 bp with a greater number of CpG sites than expected for its GC content. These regions are often GC rich and usually undermethylated. They correspond to the promoter regions of many mammalian genes.
of the sitespecific factor to the DNA? Therefore, this Review concludes with suggestions for future experi ments that are needed to further our understanding of the causes and consequences of specific transcription factor-genome interactions.
Localization of binding sites
Two decades ago, investigators were using in vitro assays or reporter constructs to define the cis elements that are necessary for basal transcriptional activity and the regions that control celltypespecific, hormonal or environmental transcriptional responses. In most cases, small promoter segments (from 500 bp to ~10 kb upstream of a TSS) were used as the starting point for mutational analyses. One common observation was that severe truncation of a fragment could cause large changes in promoter activity but that incremental deletion of the 5′ end of the fragment resulted in only minor changes in activity, suggesting that multiple transcription factor binding sites were scattered throughout the analysed region (for example, see REF. 29 ). by contrast, other stud ies found that hormonal regulation or celltypespecific transcription from a promoter could not be reproduced using reporter assays (for example, see REF. 30 ). Such results raised two important questions that are now being addressed by genomewide binding analyses: do differ ent transcription factors bind in clusters near each other, and are most of the binding sites for a given transcription factor located in proximal promoter regions?
Binding to proximal promoters. Transcription factors have been categorized into those that bind proximal promoters and those that bind enhancers 1,2 . However, in most analyses, a single binding site, or in some cases a small set of sites, was studied for a particular factor. Such focused analyses do not allow general conclusions to be drawn as to whether a factor usually binds near or distal to a promoter region. Thus, accurate categorization of factors is not possible without genomewide analysis of binding sites. Knowing the location, relative to the TSS, at which a factor binds is of interest as it can provide insight into the mechanisms by which the factor regulates tran scription (FIG. 1) . For example, factors that bind close to TSSs have been proposed to regulate transcription by stabilizing general transcription factors at the core pro moter elements; factors that bind to distal regions, either upstream or downstream of a gene, may regulate tran scription by mediating, through a looping mechanism, the protein-protein contacts between distal complexes and the general transcriptional machinery bound at TSSs. Thus, comprehensive analysis of the binding locations of a factor not only allows the development of a genomic map but also provides insight into the mechanisms by which the factor regulates transcription.
Initial largescale ChIP-chip analyses of transcription factor binding focused on the identification of binding sites near CpG islands or within 1-5 kb of the TSS of known genes 15, [31] [32] [33] [34] . Although these studies identified hundreds, and in some cases thousands, of promoters that were bound by a particular transcription factor, they were limited to target sites in proximal promoter regions, so it was not known whether the identified sites were representative of the majority of the genomic bind ing sites for a given factor. Analyses of 1% of the human genome, which began as part of the ENCyclopedia Of DNA Elements (ENCODE) pilot project and are being continued by the ENCODE Consortium and oth ers 3, [22] [23] [24] 35, 36 , have shown that transcription factors that bind almost exclusively at proximal promoters might be the exception, not the rule. Some factors, for example, E2F transcription factor family members, are almost always bound in proximal promoter regions (FIG. 2a) . In fact, it is often difficult to distinguish E2F binding patterns from the binding patterns of general transcrip tion factors, such as RNAPII or TATA box binding proteinassociated factor 1 (TAF1) 15, 22 . However, other factors that have recently been analysed by genome wide ChIP-chip or ChIP-seq, such as GATA1 and zinc finger protein 263 (ZNF263), bind to diverse regions of the genome (FIG. 2b) , including extragenic regions distant from the TSS and intragenic regions (including introns and exons). Other examples of transcription factors that have widespread binding patterns include p53, p63, the oestrogen receptor, forkhead box protein A2 (FOXA2) and transcription factor 4 (TCF4) 10, 13, 24, 36, 37 .
Although it is difficult to make accurate compari sons of binding patterns generated by different research groups using different experimental platforms, genome wide profiles for a large number of factors were compared in the ENCODE pilot project 3 . This study found that less than 10% of the factors tested had greater than 50% of their binding sites within 2.5 kb of a transcription start site (see figures in REF. 28 ). Another study, which analysed 13 sitespecific factors in mouse embryonic stem cells using ChIP-seq, also found that many binding sites were located outside proximal promoter regions 38 . Clearly, a typical reporter or in vitro assay cannot monitor the contribution to promoter activity of sites distant from the proximal promoter. These new findings of the distri bution of factors throughout the genome might explain many of the failed attempts to demonstrate accurate regu lation of a target gene using reporter assays or transgenic constructs. Also, the distributive pattern of binding seen for many factors has important implications for subse quent functional analyses. For example, it is not easy to link enhancers to specific promoters if the enhancer is between two genes but at a great distance from both; this is discussed in more detail below. and spaced ~50 kb apart 40 . The D. melanogaster genome is onetenth the size of the human genome and therefore it is not yet clear whether the same sort of clustering will be commonly found for human transcription factors.
Binding to enhanceosomes. Early studies of
Owing to the large size of the human genome and the large number of transcription factors (~1,400), most investigations into the concept of clustered binding sites creating a regulatory element have used computational tools 41 . As detailed below, bioinformatic analyses are not sufficient to determine which of all possible binding sites are actually occupied by a transcription factor in vivo. However, there is some experimental evidence that at least a few binding hot spots do exist in the human genome. An extensively studied mammalian enhancer is the interferonβ enhanceosome 42, 43 , in which eight tran scription factors bind to overlapping elements within a 55 bp region upstream of the interferonβ gene (IFNB1). This enhancer was characterized over many years using classical mutational analyses of a single regulatory ele ment. Although very few regions of the human genome have been characterized in as much detail as the IFNB1 enhancer, several other enhancer regions have been well studied, including the mouse and chicken βglobin locus control regions and the human growth hormone and major histocompatibility complex II (mHCII) enhancer regions 44 . Chen et al. analysed a set of factors that work together to mediate pluripotency and maintain the selfrenewal properties of mouse embryonic stem cells 38 . They found that some regions, termed multiple transcription factorbinding loci (mTls), were bound by several fac tors. Specifically, clusters of NANOG, OCT4 (also known as POU5F1) and SOX2 sites were identified outside pro moter regions, which suggested that these regions might be enhancers, and a subset of mTls showed strong enhancer activity in followup experiments. Identification of these mTls might have been facilitated by the fact that NANOG, OCT4 and SOX2 were previously known to cooperate in regulating the mouse embryonic stem cell transcriptome.
Unfortunately, only a handful of human factors (very few of which have been implicated in regulating the same sets of genes) have been analysed using ChIP-seq, and these factors do not seem to show a large degree of overlap in binding at locations outside promoter regions (FIG. 2b) . However, it is hard to know whether the lack of observed clustering is due to a lack of hot spots for bind ing in the human genome or to the possibility that the correct combinations of factors have not yet been stud ied. Gaining knowledge of the extent of clustered binding in mammalian genomes requires the collection of more ChIP-seq data. Genomewide analyses of enhancers based on specific histone modification patterns have also recently been initiated 45, 46 . However, identifying a poten tial enhancer region based on histone patterns does not reveal how many sitespecific factors bind to the region. If clusters of binding sites are found in mammalian genomes, they may correspond to enhancesomes that are similar to the one at IFNB1, in which multiple fac tors work together to mediate transcriptional activation. Alternatively, they may represent nonfunctional 'storage bins' for excess transcription factors, provide functional redundancy that decreases the chances that a gene may be turned off owing to mutation, or allow activation of a gene by multiple different signalling cascades.
Do consensus motifs specify binding?
In vitro studies, such as CASTing (cyclic amplification and selection of targets), and sequence comparisons of small sets of promoters known to be bound by a factor have allowed the derivation of consensus binding motifs for some transcription factors 47 . Subsequent bioinfor matic analyses that search the human genome using consensus motifs or position weight matrices -a col lection of motifs that are similar, but not identical, to the consensus motif -allow the identification of all loca tions in the genome to which a transcription factor might bind 41, 48 . This approach provides the set of all possible locations for a given factor; however, in a mammalian genome there are clearly many more occurrences of a consensus motif for a given factor than there are binding sites 37, 49 . Also, the utility of bioinformatic studies relies on the assumption that transcription factors are recruited to the genome in vivo by motifs similar to those identified in in vitro studies. These caveats have led to uncertainties as to the importance of consensus motifs for in vivo binding. ChIP-chip and ChIP-seq studies have allowed investigators to address two important questions con cerning motif usage: what percentage of binding sites contain a consensus motif, and what influences whether a specific motif is bound by a particular factor? Figure 3 | Models for recruitment of factors to sites that lack consensus motifs. a | A transcription factor (X) could bind to its consensus motif and loop, as a result of protein-protein interactions, to another transcription factor (TF) bound to a different binding site (TFBS) that is located at a distant region of the chromosome. In this case, because formaldehyde can create both protein-DNA and protein-protein crosslinks, chromatin immunoprecipitation (ChIP) assays for factor X would enrich for a region containing its own consensus motif and a region bound by the other factor. b | Factor X could be recruited to a sequence by protein-protein interactions with another transcription factor in a manner completely independent of its DNA-binding abilities. In this case, ChIP assays would detect binding of factor X at a region that has no match to its consensus or position weight matrix (PWM). c,d | Factor X could bind to a sequence that has a low match to its PWM and be anchored on the genome by protein-protein interactions with a nearby factor (c) or be attached by interaction with a co-activator to a specifically modified -for example, acetylated (Ac) -histone (d). In both cases, ChIP assays would detect binding of factor X at a region that contains a low match to its PWM.
Heterochromatin
Chromatin that is characterized by very dense packing of DNA, which makes it less accessible to transcription factors. Certain regions of the genome, such as centromeres and telomeres, are always heterochromatinized (constitutive heterochromatin regions), whereas other regions are densely packed and repressed only in certain cells (facultative heterochromatin regions).
DNA methylation
An epigenetic DNA modification that can be added and removed without changing the original DNA sequence and that is characterized by the addition of a methyl group to the number 5 carbon of the cytosine pyrimidine ring.
Plant homeodomain finger
A 50-80 amino acid domain that contains a Cys4-His-Cys3 motif. It is found in more than 100 human proteins, several of which are involved in chromatin-mediated gene regulation.
Motif enrichment in binding regions. Although some factors seem to be recruited to a majority of their binding sites by a common motif, other factors seem to have a more diverse set of recruitment mechanisms. For example, members of the E2F family do not seem to require a spe cific motif for binding in vivo 49 . by contrast, the binding sites for factors such as p63, signal transducer and activator of transcription 1 (STAT1) and neuronrestrictive silencer factor (NRSF, also known as REST) show high enrichment for a specific motif 16, 20, 37 . It should be stressed that binding detected at sites that lack a consensus motif is not caused by a general, lowaffinity DNAbinding activity. ChIP-chip and ChIP-seq measure DNA-protein interactions as an average of individual binding events in millions of cells, and a peak at a site without a motif can be as high and as sharp as a peak located over a consensus motif, which is inconsistent with random protein-DNA interaction.
Several mechanisms have been proposed to explain how recruitment of a specific transcription factor can occur in the absence of a consensus motif (FIG. 3) . These include: binding at a distal site that contains a consensus motif and looping to the site in question through proteinprotein interactions (perhaps through a coactivator or corepressor); 'piggyback' binding that is mediated by protein-protein interactions with a second factor and that does not involve the DNAbinding domain of the first factor; or assisted binding to a site that is similar to the consensus site, which is enhanced by protein-protein interaction with another sitespecific DNAbinding factor or with a specifically modified histone. Clearly, the greater the contribution of protein-protein interactions to the genomic localization of a factor, the greater the difficulty of using a strictly bioinformatic approach for identifying in vivo binding sites.
Sorting binding sites for a factor into subsets that contain or lack a specific motif might eventually provide insight into alternative recruitment or regulatory mecha nisms mediated by that factor; the ability of a factor to be recruited to the genome in more than one way might allow it to participate in multiple different signalling pathways. For example, serum response factor (SRF) is ubiquitously expressed, but its activity is modulated at several levels, including protein-protein interaction 50, 51 . Perhaps recruit ment of SRF by a consensus motif allows the regulation of one set of targets in many cell types, whereas stabilized binding, mediated by protein-protein interaction, to sites lacking the consensus motif allows the constitutively expressed SRF to also have some celltypespecific func tions. It should be noted that even factors that prefer to bind to regions containing a specific motif can also have subsets of binding sites that lack that motif 52, 53 . A recent study has shown that the ability of a factor to bind to more than one motif is not necessarily attributable to proteinprotein interactions; the same property can be seen for purified proteins in in vitro assays. Using protein binding microarrays, badis et al. 54 found that approximately half of a set of 104 mouse DNAbinding proteins recognized multiple different sequence motifs. Such studies suggest that motif analysis of ChIP-seq data should be performed under the assumption that more than one motif can be present in the set of identified binding regions. Do epigenetic modifications influence motif usage? As dis cussed above, a major difficulty with using a bioinformatics motifdriven approach for identifying binding sites is that it is clear that only a small percentage of all occurrences of a motif are actually bound by that factor. Therefore, the majority of regions in the genome that contain a consensus motif for a given factor are not occupied. lack of binding in certain regions of the genome could be a consequence of the chromatin structure (the close packing of nucleosomes in heterochromatin might make binding sites inaccessible) or of DNA methylation (methyl ation of a crucial residue in the recognition motif might result in reduced binding affinity). However, in a study of unoccupied E2F consensus sites in a human breast cancer cell line, neither repressive histone modifications (that is, histone H3 trimethylated on lysine 9 or lysine 27) nor DNA methylation seemed to account for the lack of E2F binding 49 . An alternative pos sibility is that specific histone modifications enhance tran scription factor recruitment to certain genomic regions. For example, recent ChIP-chip and ChIP-seq studies have shown that histone H3 monomethylated at lysine 4 (H3K4me1) is localized at enhancer regions 45, 46 . It is not known whether the histone modification or the binding of a factor comes first, but it is possible that certain fac tors might have an affinity for a specific histone modifica tion. For example, plant homeodomain finger (PHD finger) domains in several proteins, such as the TAF3 subunit of TFIID, bromodomain PHD finger transcription fac tor (bPTF) and inhibitor of growth family, member 2 (ING2), can mediate a specific highaffinity interaction with histone H3 trimethylated on lysine 4 (REFS 55-58), which is highly localized to promoter regions 3, 46 . PHD domains in sitespecific factors or coactivators may help to localize DNAbinding factors to consensus motifs located in proximal promoters; other domains may medi ate interactions of transcription factors or coactivators with H3K4me1, which may result in preferential occupancy of motifs located in enhancer regions (FIG. 3d) .
Although each of the models presented in FIG. 3 is pos sible, it is generally not clear why some consensus motifs are occupied and others are not. Once we have binding maps for hundreds of factors, it may become obvious that binding of a factor to one motif commonly prevents another motif from being occupied by a different factor. For example, an ETS1 and an E2F binding site overlap in the MYC promoter, and it is only after mutation of the E2F site that ETS1 can bind in vivo 59 . Alternatively, as described above, we might find that stable binding is rarely mediated by a single DNA-protein interaction and requires cooper ative binding between adjacent sitespecific factors, which may be achieved by either direct interaction between the two sitespecific factors or indirect interaction through a platform such as a coactivator or corepressor 60 .
Are all occupied binding sites important?
The discovery of thousands of binding sites by genome wide profiling has raised two important questions: can a factor occupy a certain site in many cell types but regulate trans cription by binding to that site in only one (or a few) cell types, and is functional redundancy a builtin safeguard for maintaining accurate regulation of the genome? Nature Reviews | Genetics 
Small interfering RNAs
Small antisense RNAs (20-25 nucleotides) that can be directly introduced into cells or be generated in cells from longer dsRNAs. They serve as guides for the cleavage of homologous mRNA in the RNA-induced silencing complex.
Understanding gene expression data. Several recent studies have attempted to assess the functional impor tance of each of the thousands of binding sites for a given factor by altering the level of that factor in the cell. A frequent finding is that changing the level of a factor alters the expression level of 1-10% of the potential tar get genes 12, 37, 61, 62 . One interpretation of these results is that most binding is not functional. There are, however, several caveats to this conclusion.
First, the assignment of a specific binding site to a target gene is not always accurate. Investigators use the most expedient approach, which is to assign the bind ing site to the nearest known gene, but this can lead to incorrect assumptions in cases of longrange regulation, undiscovered genes or alternative upstream promoters. Changes in the expression level of a gene that does not have a nearby binding site for the factor that is altered might initially be interpreted as indicative of indirect regulation, but might be due to direct regulation by a site many thousands of kilobases away (FIG. 4a) .
Second, altering the expression of a human transcrip tion factor is fraught with problems.Downregulation of a transcription factor in human cells is usually accom plished using small interfering RNAs or short hairpin RNAs. However, loss of expression is rarely complete; it is pos sible that reducing the level of a transcription factor by 90% may not have functional consequences if there is a tenfold excess of the factor under normal conditions. There are a number of reasons, other than a lack of function, why reduction in the level of a transcription factor might not result in a change in expression of the predicted target gene. a | The transcription factor (dark blue oval) regulates gene C, which is distal to the binding site; therefore, genes A and B will not show a change in expression following knockdown of the factor, even though they are nearer to the transcription factor than gene C. b | Knockdown of a factor (dark blue ovals) with a small interfering RNA (not shown) does not lower the level below that needed for full binding site occupancy; therefore, expression of target genes is not affected. c | Knockdown of a factor (pink oval) results in full occupancy by another family member (dark blue oval) at a site that, under normal conditions, is bound interchangeably by both family members; expression of the target gene (A) is not affected because the family members are redundant in function. d | Regulation is dependent on the ubiquitous site-specific factor (factor X) in combination with cell-type-specific factors. In this example, factor X is bound to the promoter regions of gene A and gene B in both liver and breast cells, and genes A and B are expressed in both tissues. However, in liver cells, factor X is not involved in regulation of gene B because there is no binding site for the liver-specific factor (light blue oval) near the factor X binding site in the gene B promoter. Conversely, in breast cells, factor X regulates gene B through interaction with the breast-specific factor (pink oval) but does not regulate gene A because there is no binding site for the breast-specific factor near the factor X site in the gene A promoter. Thus, different subsets of target genes may show changes in expression in different cell types when levels of the ubiquitous site-specific factor are reduced. The triangles represent other site-specific factors that cooperate with the liver-or breast-specific factors to activate transcription. many studies are performed in cancer cell lines that can have, as shown by western blot, a massive increase in the amount of a particular transcription factor compared with a normal cell. Thus, what seems to be an efficient knockdown in a cancer cell line may leave sufficient lev els of the factor for normal regulation (FIG. 4b) . very few studies have actually shown a reduced level of binding of a transcription factor in knockdown cells by ChIP-chip or ChIP-seq. To overcome this problem, mouse knock outs can be used. However, cells from these mice could undergo compensation for loss of a factor during devel opment, which might result in related proteins being selected to regulate the target genes. Third, closely related family members might bind to the same sites and have the same function. Thus, elimina tion of one family member could allow a higher level of binding of another family member (FIG. 4c) . Finally, only a small proportion of the binding sites for a factor might be functional in a given cell type. For example, if a celltype specific partner needs to be recruited for transcriptional activity, then binding of the sitespecific factor is necessary but not sufficient for transcription of a target gene (FIG. 4d) . Thus, knockdown of a factor in ten cell types may show ten different subsets of affected target genes. To address this possibility, one would have to collect ChIP-chip or ChIP-seq data and gene expression data before and after knockdown of the factor in a diverse set of cell lines. However, most transcription factors have been studied on a genomewide scale in only one cell type. The ENCODE Consortium has chosen a set of different cell types for thorough characterization of binding of a large number of sitespecific factors, and initial studies seem to show that factors can be grouped into those that show very little cell type specificity in binding, such as E2F4 and YY1 (H. O'Geen and P.J.F., unpublished observations), and those that show considerable celltypespecific binding, such as JunD (D. Raha and m. Snyder, personal com munication) and the oestrogen receptor 15, 63 . Continuing studies will address whether factors that have small num bers of celltypespecific binding sites show regulation of a large percentage of their target genes in a given cell type compared with factors that show constitutive binding to a large number of sites and might regulate only a subset of target genes in each cell type.
Functional redundancy in clusters. many previous analyses of transcriptional regulation assumed that transcription factors act as 'individuals' with each fac tor having a specific role in regulating a particular gene and a specific mechanism of action. However, a factor might act as an individual at a subset of its sites (per haps those that show altered regulation of a nearby gene following loss of or enhanced expression of that factor) but have a very different 'community' function at other sites. For example, binding of a set of factors in a cluster might regulate transcription throughout a chromatin domain by helping to keep an open chromatin structure through recruitment of histone acetyltransferases or his tone methyltransferases. loss of a single factor would not affect transcription of the nearby genes; it would take the removal of a large proportion of factors bound in the cluster to alter gene regulation (FIG. 5a) . Alternatively, a cluster of bound factors could serve to define a local genomic search space for a second binding factor. Recent studies have shown that many transcription factors have a very fast dissociation rate in vivo 64 . A factor might rebind to the same region of DNA but in a nonspecific manner and begin scanning for its highaffinity binding site. If the factor moves unimpeded in the wrong direc tion, there could be a detrimental time lag before it finds another binding site. However, a cluster of bound factors that blocks scanning in the wrong direction might favour release, rebinding and perhaps scanning in the correct direction. That is, binding of a cluster of factors might affect the expression of a nearby gene that is controlled by an entirely different factor. Again, reduced expression of one of the 'bumper proteins' may be fairly inconse quential; loss of several factors from the cluster would be required to cause a significant effect (FIG. 5b) . Data to support either of these possibilities are not yet available owing to the lack of genomewide binding i nformation for most transcription factors. Next steps for genomic landscapes Significant progress has been made in mapping transcrip tion factor binding sites throughout the genome, and expanding the number of transcription factors for which we have information about global binding patterns is important; however, simply collecting genomewide data sets will not be sufficient to answer all of the crucial ques tions. A number of methodological problems now need to be tackled.
Accurate target gene assignment. It is not yet possible to conclusively link a specific binding site with a specific target gene. It remains possible that many binding sites, which may be scattered tens or hundreds of kilobases away from each other (or perhaps even on different chromo somes), all cooperate to regulate a single target gene. If so, linking a binding site to the nearest gene is not appropriate and will lead to both an incorrect assignment of target genes and an underestimation of the number of binding sites that contribute to transcriptional regulation. methods that define features of chromosomal architecture, such as transcription factories 65, 66 , could aid in identifying coregu lated groups of genes, perhaps by collapsing thousands of seemingly unlinked binding sites into a smaller number of interactomes. For example, chromosome conformation capture (3C), a technique that can identify chromosomal loops mediated by multiple longrange protein-protein interactions 67 , may reveal a connection between an enhancer binding protein and the promoter of a distant gene and thereby allow a more accurate interpretation of the regulatory role of that factor in the cell.
Comprehensiveness. Although ChIP-seq can identify all the binding sites for a given factor in a given cell type, researchers may still face the daunting challenge of per forming ChIP-seq experiments in many different cell types to determine all possible binding sites for a given factor. The ENCODE Consortium is currently perform ing studies to estimate how many cell types are needed to identify most binding sites for a set of factors. If a lim ited, but diverse, set of cell types can be identified that is representative of many different human tissues, then genomewide analyses may not have to be performed in every possible cell type.
Functional analysis of specific regulatory elements. most approaches that are designed to study the relationship between a specific cis element and a potential target gene involve creating a reporter construct that includes the regulatory element of interest 4, 68 . Unfortunately, because reporter analyses remove the cis element from its normal genomic context, they cannot reveal effects on long range regulation. Precise mutation or deletion of a single cis element in the genome can be performed in model organisms such as yeast, for which efficient methods for substituting genomic sections have been developed.
Theoretically, mutations could be engineered to alter a specific binding site in animal models or human cell lines. However, mutagenesis of specific small regions of the mouse or human genome is not routinely used to study the significance of individual binding sites owing see FIG. 1 ). This provides support for step 1, in which promoter activity can be increased by the interaction of site-specific DNA-binding factors (red trapezoid) with cis elements (dark blue box) in the proximal promoter region, which stabilizes the recruitment of transcriptional machinery through direct interaction between the site-specific factor and the general factors. Promoter activity can be further increased by the binding of a site-specific factor (orange octagon) to an enhancer region (step 2). However, ChIP-chip and ChIP-seq studies have revealed that step 2 is not sufficient for high levels of promoter activity, and thus a new step has been proposed: the binding of a cell-type-specific partner protein (pink octagon) that allows the recruitment of a co-activator, which provides a constitutively bound factor with a cell-type-specific function (step 3). Currently, the projected later steps remain as shown in FIG. 1 : the enhancer factors can stimulate transcription by (bottom left) recruiting a histone-modifying enzyme to create a more favourable chromatin environment for transcription or (bottom right) recruiting a kinase that can phosphorylate (P) the carboxy-terminal domain of RNAPII and stimulate elongation. Ac, acetylated histone; HAT, histone acetyltransferase.
to low frequencies of homologous recombination that limit the efficiency of this technique. New approaches in sitespecific targeting of DNAses using artificial zinc fingers 69 might improve the efficiency of genomic replacement, so mutagenesis could become a practical method for dis secting the role of individual cis elements. Furthermore, artificial zinc fingers fused to transcriptional activation or repression domains have been used to specifically regulate cellular promoters 70 . It is therefore possible that artificial zinc fingers (without either an activation or repression domain) could be used to simply block access of a fac tor to a single binding site in the genome, but this has not yet been demonstrated successfully. Other possible methods include the use of pyrroleimidazole poly amides or peptide nucleic acids to bind to (and perhaps also mutate) specific cis elements in the genome [71] [72] [73] . Although few studies have used these methods to target a specific site, and even fewer have examined the conse quences of such agents on the entire transcriptome, they do hold the promise of providing a method for testing the function of a specific binding site in its natural genomic context.
Conclusions
ChIP-chip and ChIP-seq have greatly advanced our understanding of gene regulation. First, genomic studies have confirmed that RNAPII and general and sitespecific factors are bound to thousands of proximal promoters that are active at very low levels [73] [74] [75] , thus supporting the first step in the model set out at the beginning of this Review. These studies have also revealed that binding of a factor to an enhancer region can be necessary, but not suf ficient, for high levels of promoter activity, which leads to the inclusion of a new step in the model (FIG. 6, step 3) : the binding of a celltypespecific partner protein that allows the recruitment of a coactivator, which results in celltypespecific functioning of a constitutively expressed factor. Although the principle that binding of a transcription factor can be necessary, but not suf ficient, for regulation of a specific gene was previously established using 'onegeneatatime' approaches, it was not clear whether a cooperative mode of regulation was the exception or the rule for most genes. Recent genome wide analyses suggest that this type of regulation is com mon. For example, of the ~3,700 OCT4, ~4,500 SOX2 and ~10,000 NANOG binding sites identified in mouse embryonic stem cells, only a small number of regions were bound by all three factors and by the coactivator p300 (REF. 38 ). These studies support the hypothesis that the occupancy of an upstream site by a single factor (OCT4) has no functional effect (as in FIG. 6, step 2 ), but binding of SOX2 and/or NANOG near to the occupied OCT4 site resulted in recruitment of the p300 coactivator (FIG. 6,  step 3 ) and transcriptional activation.
Other discoveries have also stimulated new ideas con cerning longrange and combinatorial regulation. These include the findings that most transcription factors bind to thousands of places in the genome, that binding sites are not localized only in proximal promoter regions and that some binding sites lack sequences similar to the con sensus motif. However, current genomic studies have not yet determined whether most transcription factors cluster at hot spots in the human genome or with what frequency binding events have a functional outcome. The answers to these two questions will require the genomic profiling of many more factors. It is likely that a true understand ing of the role of a given factor at a particular site in the genome will require the identification of all other factors binding nearby and knowledge of histone modifications in that region. These studies will be best performed by cooperation between large groups and individual investi gators. The groups -such as the ENCODE Consortium and the NIH Roadmap Epigenomics Program -can identify binding sites for a large number of transcription factors and develop reference epigenomes in many differ ent cell types. Individual investigators can then perform the followup functional analyses of the role of a specific factor in a particular cell type. The next several years of largescale data collection should provide investigators with a plethora of information that will form the basis for hundreds of followup experiments that address important biological questions.
Transcription factory
A nuclear subcompartment that is rich in RNA polymerases and transcription factors, and in which there is clustering of active genes.
Interactome
A complete set of macromolecular interactions (physical and genetic). Current use of the word tends to refer to a comprehensive set of protein-protein interactions. However, the protein-DNA interactome (a network formed by transcription factors and their target genes) is also commonly studied.
Artificial zinc finger
Chimaeras of zinc finger domains -small protein domains that coordinate one or more zinc ions and that are commonly found in mammalian transcription factors -and an effector domain (for example, an activator, repressor, methylase or nuclease). Linking together six zinc fingers produces a target site of 18 bp, which is long enough to be unique in all known genomes.
